跳至主要内容
临床试验/NCT01627522
NCT01627522已完成2 期

Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate

Shiraz University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Perioperative Hb Drop

研究概览

简要总结

Preoperative use of finastride will decrease the amount of perioperative blood loss during and after TURP

The effect of finastride on decreasing the amount of perioperative blood loss during and after TURP is dose dependent

Finastride will decrease microvascular density in prostate tissue and this effect is dose dependent

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Patients with BPH that require TURP

排除标准

  • •Previous prostate surgery
  • •Prostate Cancer
  • •Coagulopathy
  • •The use of NSAIDs, Anticoagulants, Antiplatelet drugs

研究组 & 干预措施

Finastide low dose

Active Comparator

2 weeks of daily 5mg finastride before operation

干预措施: TURP (Procedure)

Finastide high dose

Active Comparator

4 weeks of daily 5mg finastride before operation

干预措施: TURP (Procedure)

Control

No Intervention

Control

结局指标

主要结局

Perioperative Hb Drop

时间窗: 24 hours after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alireza Aminsharifi

Assistant professor of Urology

Shiraz University of Medical Sciences

研究点 (1)

Loading locations...

相似试验